Accession 457
Title Immunosignature system for diagnosis of cancer
Summary An alternative to the typical reductionist biomarker paradigm is an assay we call an "immunosignature." This approach leverages the response of antibodies to disease-related changes, as well as the inherent signal amplification associated with antigen-stimulated B-cell proliferation. To perform an immunosignature assay, the antibodies in diluted blood are incubated with a microarray of thousands of random sequence peptides.
Journal Proc Natl Acad Sci U S A.
Publish date July, 2014
Corresponding Author Phillip Stafford
Array Type Peptide array
Species Homo sapiens
Raw data link


Link to PubMed

PubMed ID:25024171